Is externalising the tech transfer function for academic institutions a key to succeed?

Technology transfer offices play a central role in the biotech ecosystem, as they are meant to
bridge the gap between bench and bedside and succeed in commercialising an academic
discovery. As most new biotech start-ups arise out of IP resulting from academic research, the
efficiency of this system is of outmost importance.
This panel discussion will highlight both successes and limits in that externalisation of tech
transfer approach.